Showing posts with label Treatment of Patients with Advanced Renal Cell Carcinoma. Show all posts
Showing posts with label Treatment of Patients with Advanced Renal Cell Carcinoma. Show all posts
Friday, December 2, 2016

FDA Approves Lenvima (lenvatinib) for the Treatment of Patients with Advanced Renal Cell Carcinoma

›
In continuation of my update on  Lenvatinib   Lenvatinib Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA)...